1h Free Analyst Time
The central nervous system (CNS) stimulant drugs market is forecasted to grow by $6486.71 mn during 2022-2027, accelerating at a CAGR of 5.8% during the forecast period. The report on the central nervous system (CNS) stimulant drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in CNS disorders, approval of new stimulants, and increasing use of stimulants worldwide.
The central nervous system (CNS) stimulant drugs market is segmented as below:
By Distribution Channel
- Hospitals
- Others
By Application
- Attention-deficit hyperactivity disorder
- Narcolepsy
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the central nervous system (CNS) stimulant drugs market covers the following areas:
- Central nervous system (CNS) stimulant drugs market sizing
- Central nervous system (CNS) stimulant drugs market forecast
- Central nervous system (CNS) stimulant drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global central nervous system (CNS) stimulant drugs market: Astellas Pharma Inc., Azurity Pharmaceuticals Inc., Elite Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Ironshore, Jazz Pharmaceuticals Plc, KemPharm Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, Sanofi SA, Shionogi and Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Tris Pharma Inc., Viatris Inc., and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increased uptake of new-generation drugs.'
According to the report, one of the major drivers for this market is the rise in CNS disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Astellas Pharma Inc.
- Azurity Pharmaceuticals Inc.
- Elite Pharmaceuticals Inc.
- Hisamitsu Pharmaceutical Co. Inc.
- Ironshore
- Jazz Pharmaceuticals Plc
- KemPharm Inc.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Purdue Pharma LP
- Sanofi SA
- Shionogi and Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Tris Pharma Inc.
- Viatris Inc.
- Thermo Fisher Scientific Inc.
Related Reports
From
From
From
Global Autism Spectrum Disorder Therapeutics Market 2023-2027
- Report
- 157 Pages
- Global
From
Global Insomnia Therapeutics Market 2023-2027
- Report
- 151 Pages
- Global
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
